Mithra Pharmaceuticals S.A. (MITRA)の価格はいくらですか

Mithra Pharmaceuticals S.A. (MITRA)の価格は$0.25620952です

Mithra Pharmaceuticals S.A. (MITRA)の時価総額は何ですか

Mithra Pharmaceuticals S.A. (MITRA)の時価総額は$17.14Mです

Mithra Pharmaceuticals S.A.（MITRA）の株価履歴

Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège, Belgium, specializes in the creation, production, and worldwide commercialization of advanced therapeutic solutions. The company's core focus areas include contraception, the management of menopause, and treatments for hormone-dependent cancers. Its robust development pipeline features Estelle, a combined oral contraceptive that has successfully concluded Phase III clinical trials, and Donesta, an estetrol-based oral hormone treatment currently undergoing Phase III development for menopausal symptoms. Mithra's product portfolio also encompasses Myring, a hormonal contraceptive vaginal ring; Tibelia, a therapy designed to address both menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant targeting prostate and breast cancers, as well as various benign gynecological conditions. Furthermore, the company markets NEXTSTELLIS, an established oral contraceptive pill. Their offerings span diverse pharmaceutical formats, including polymeric devices, implants, sterile injectable medications, and hormonal tablets.

年	パフォーマンス
2024	-79.92%
2023	-68.31%
2022	-82.82%
2021	-7.44%
2020	-13.95%
2019	18.19%
2018	100.30%
2017	32.01%
2016	-15.12%
2015	0.00%

年

パフォーマンス

2024

-79.92%

2023

-68.31%

2022

-82.82%

2021

-7.44%

2020

-13.95%

2019

18.19%

2018

100.30%

2017

32.01%

2016

-15.12%

2015

0.00%

企業	株価	変化率 1年%	国
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$162.21	25.48%	DE
Takeda Pharmaceutical Company Limited 4502.T	$37.33	22.12%	JP
Galderma Group AG GALD.SW	$220.57	31.75%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$20.69	10.80%	IN

企業

株価

変化率 1年%

国